货号: | T2145 |
CAS号: | 162635-04-3 |
供应商: | 详询 |
数量: | 详询 |
英文名: | Temsirolimus (CCI-779, NSC 683864) |
保质期: | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -2173℃ for several months. |
保存条件: | RT |
规格: | 1mg/10mg/25mg/50mg/100mg/1ml/10mM |
ID:T2145
PURITY:0.98
Formula:C56H87NO16
MolWt:1030.29
Appearance:白色粉末
Solubility:G4DMSO 75 mg/mL;Ethanol 75 mg/mL
Bioactivity:Temsirolimus is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the FDA in late May 2007, and was also approved by the European Medicines Agency (EMEA) on November 2007. It is a derivative of sirolimus and is sold as Torisel.
Status:
Pathways:PI3K/Akt/mTOR Signaling
Target:mTOR inhibitor
Receptor:mTOR